Option to Acquire Garfield Hills Property in Nevada

Option to Acquire Garfield Hills Property in Nevada

(TheNewswire)

Vancouver, British Columbia, November 18, 2025 TheNewswire - Lexston Mining Corporation (the "Company" or "Lexston" ) (CSE: LEXT) (OTCQB: LEXTF) (Deutsche Börse Frankfurt: L75) announces that further to the Memorandum of Understanding News Release dated November 12, 2025 a definitive Assignment Agreement, has been entered into, to acquire 128 mineral claims located in Mineral County, Nevada, USA, known as the Garfield Hills Property (the "Garfield Property" ).

The Company entered into an assignment agreement with 2730573 Alberta Ltd. , an Alberta corporation, and Imperium Mine Supply Corp . (a Nevada company and a subsidiary of 2730573 Alberta Ltd.) and three individual optionors dated November 18, 2025 (the "Assignment Agreement" ) and was assigned the Option To Acquire the Garfield Hills Property Term Sheet between 2730573 Alberta Ltd. and three individual optionors dated August 31, 2025 (the "Term Sheet" ) and the Definitive Option Agreement between Imperium Mine Supply Corp. and three individual optionors effective as of October 22, 2025 (the "Option Agreement" ).

Lexsto n Mining Corporation Initiates Development Plans in Walker Lane.  Jag Bal, CEO of Lexston Mining Corporation, commented on the completion of the definitive Assignment Agreement: "Completing this definitive Assignment Agreement allows Lexston to begin our plan to develop and explore an active area of Walker Lane in Nevada. This area is of particular interest, as it includes Guardian Metals, who have discovered high-grade mineralization of copper, gold, and silver at the northern border of our claims. We are eager to commence our exploration plans in the near future."

Pursuant to the Assignment Agreement, as consideration for the assignment, the Company will pay $45,000 and will issue 1,600,000 shares to 2730573 Alberta Ltd.

Furthermore, to earn 100% interest in the Garfield Property, pursuant to the Option Agreement, the Company will make cash payments in the amount of $130,000 and will issue shares valued at $90,000 for the total consideration of $220,000 to three optionors as follows:

1) within six months from August 31, 2025, $10,000 payable in cash and $15,000 in shares;

2) within 12 months from August 31, 2025, $25,000 payable in cash and $20,000 in shares;

3) within 24 months from August 31, 2025, $40,000 payable in cash and $25,000 in shares; and

4) within 36 months from August 31, 2025, $55,000 payable in cash and $30,000 in shares.

The optionors have a right to receive 1.5% of net smelter returns on all mineral products produced from all claims comprising the Garfield Property.  The Company will have the right to repurchase 1.0% of the 1.5% net smelter returns for a one-time payment of $150,000.

The Assignment Agreement is subject to the acceptance by the Canadian Securities Exchange.

About Lexston Mining Corporation

The Company is a Canadian mineral exploration company, focused on the acquisition and development of mineral projects, with the objective to enhance value to all its stakeholders.  The Company has a mineral exploration project in British Columbia.

The Company (OTCQB: LEXTF) trades on the OTCQB Venture Market for early stage and developing U.S. and international companies. Companies are current in their reporting and undergo an annual verification and management certification process. Investors can find Real-Time quotes and market information for the company on www.otcmarkets.com .

On Behalf of the Board of Directors

LEXSTON MINING CORPORATION

Jagdip Bal

Chief Executive Officer

Telephone: (604) 928-8913

Email: info@lexston.ca

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

Forward-looking statements

This news release contains "forward-looking information" under applicable Canadian securities legislation. Such forward-looking information reflects management's current beliefs and are based on a number of estimates and/or assumptions made by and information currently available to the Company that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors that may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking information. Readers are cautioned that such forward-looking information are neither promises nor guarantees and are subject to known and unknown risks and uncertainties including, but not limited to, general business, economic, competitive, political and social uncertainties, uncertain and volatile equity and capital markets, lack of available capital, actual results of exploration activities, environmental risks, future prices of base and other metals, operating risks, accidents, labour issues, objections by aboriginal people, delays in obtaining governmental approvals and permits, obtaining consents of aboriginal people and other risks in the mining industry.

These forward-looking statements include but are not limited to the definitive assignment agreement regarding the Garfield Property, quality and mineralization of the Garfield Property,  timing of the exploration program, goals of the exploration program, obtaining financing, obtaining exploration permits, exploration of properties for minerals, liquidity of the common shares of the Company and future financings of the Company. These statements reflect management's current estimates, beliefs, intentions, and expectations. They are not guarantees of future performance. The Company cautions that all forward-looking statements are inherently uncertain and that actual performance may be affected by many material factors, many of which are beyond the Company's control.  Such factors include, among other things: risks and uncertainties relating to the acquisition of new properties, liquidity of the common shares of the Company, financings, the market valuing the Company in a manner not anticipated by management of the Company.  Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, the Company does not undertake to publicly update or revise forward-looking information.

The Company is presently an exploration stage company. Exploration is highly speculative in nature, involves many risks, requires substantial expenditures, and may not result in the discovery of mineral deposits that can be mined profitably. Furthermore, the Company currently has no reserves on its properties.  Investment in the securities of the Company is risky.  As a result, there can be no assurance that such forward-looking statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements.

Copyright (c) 2025 TheNewswire - All rights reserved.

News Provided by TheNewsWire via QuoteMedia

LEXT:CNX
The Conversation (0)
Quantum Biopharma

Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

Reward to be Paid if Information Contributes Significant Evidence Leading to a Trial Victory or Settlement in Landmark USD $700 Million+ Lawsuit

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol... Keep Reading...
Imagion Biosystems

Phase 2 HER2 Clinical Trial Manufacturing Commenced, WSU Imaging Optimisation Program Underway

Imagion Biosystems (ASX: IBX) (Company or Imagion), a company dedicated to improving healthcare outcomes through the early detection of cancer utilising its proprietary MagSense® imaging technology, is pleased to provide shareholders with a progress update regarding the Company’s business and... Keep Reading...
Stethoscope on stacked gold coins, symbolizing healthcare costs or medical finance.

Trump Tariffs to Raise US Medical Device Costs, Hospitals Hold Off on Stockpiling

President Donald Trump’s new round of tariffs —this time targeting copper— has intensified concerns about rising costs across key sectors, including healthcare. But despite significant price pressures on steel, aluminum, and now copper, all vital to medical device production, there is no... Keep Reading...
Actinogen

Actinogen confirms 100th participant in XanaMIA phase 2b/3 Alzheimer’s disease trial and interim analysis timeline

Actinogen Medical ASX: ACW (“ACW” or “the Company”) is pleased to announce that the 100th participant in its pivotal XanaMIA phase 2b/3 randomized trial of Xanamem® for Alzheimer’s disease (AD) has now passed all screening tests and is scheduled for randomization and treatment in July. This... Keep Reading...
Emyria Limited

Medibank to Fund Emyria’s PTSD Program at Perth Clinic

Emyria Limited (ASX: EMD) (“Emyria”, or the “Company”) a leader in developing and delivering innovative mental health treatments, is pleased to announce that Medibank Private Limited (“Medibank”), Australia’s largest private health insurer, has commenced funding for eligible customers to access... Keep Reading...
ASX:HIQ

HITIQ Announces Exclusive Global Agreement with Shock Doctor for PROTEQT Instrumented Mouthguard

Common Shareholder Questions – Entitlement Offer

HITIQ Limited (ASX: HIQ) (HITIQ or the Company), a pioneer in concussion management, proudly announces an exclusive global agreement with Shock Doctor, the world’s leading mouthguard innovator. This landmark agreement marks Shock Doctor’s two-year effort to design a mouthguard that will... Keep Reading...

Latest Press Releases

Related News